Effect of neurofeedback and cognitive rehabilitation in treatment of opium and heroin addicts

Comparison of the Effectiveness of LORETA Z Score Neurofeedback with Cognitive Rehabilitation on Decreasing of Craving in Opioid Addicts

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170924036386N1

Enrollment

Registered

2018-01-08

Start date

2017-07-23

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioids Addiction. Mental and behavioural disorders due to use of opioids

Interventions

Intervention 1: Cognitive rehabilitation by Dot Probe software. 15 sessions(each session: 20 minute) for everybody in cognitive rehabilitation group will be done in MMT center. Pre and post tests of

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Opium and heroin addicts Age range: 18-70 Males Drug use: Methadone

Exclusion criteria

Exclusion criteria: Age> 70 y/o Females Methadone> 100 mg/d Non opioides addicts

Design outcomes

Primary

Measure	Time frame
Craving. Timepoint: Begin-mid- end of study. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
??Addiction Severity Index. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Recovery assessment scale. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;LDQ. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Stroop Task. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Quality of Life. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Anxiety. Timepoint: At the beginning, middle and end of the study. Method of measurement: Questionnaire.;Depression. Timepoint: At the beginning, middle and end of the study. Method of measurement: Questionnaire.;Response inhibition. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Attention bias. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.	—

Measure

Time frame

??Addiction Severity Index. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Recovery assessment scale. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;LDQ. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Stroop Task. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Quality of Life. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Anxiety. Timepoint: At the beginning, middle and end of the study. Method of measurement: Questionnaire.;Depression. Timepoint: At the beginning, middle and end of the study. Method of measurement: Questionnaire.;Response inhibition. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.;Attention bias. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Faridi

Zanjan University of Medical Sciences

arf1347@yahoo.com+98 24334206519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026